hiv

  1. Mij

    Pharmacokinetics and safety of one-yearly lenacapavir; a phase 1, open-label study, 2025, Vamshi Jogiraju, PhD et al

    Summary Background Long-acting antiretrovirals can address barriers to HIV pre-exposure prophylaxis (PrEP), such as stigma and adherence. In two phase 3 trials, twice-yearly subcutaneous lenacapavir was safe and highly efficacious for PrEP in diverse populations. Furthering long-acting PrEP...
  2. forestglip

    918 – HIV Infection and Long COVID: A RECOVER Program, EHR-Based Cohort Study, 2025, Hawkins et al

    918 – HIV Infection and Long COVID: A RECOVER Program, EHR-Based Cohort Study Kellie L. Hawkins, Dima Dandachi, Colby Lewis, M. Daniel Brannock, Zoe Verzani, Saajjad Abedian, Sohrab Jaferian, Shannon Wuller, Jennifer Truong, Margot Gage Witvliet, Kristen Marks, Edward M. Gardner, Ighovwerha...
  3. forestglip

    Prevalence of post-acute sequelae of SARS-CoV-2 infection in people living with HIV: a systematic review with meta-analysis, 2024, Pouliopoulou et al

    Prevalence of post-acute sequelae of SARS-CoV-2 infection in people living with HIV: a systematic review with meta-analysis Dimitra V. Pouliopoulou, Nicole Billias, Joy C. MacDermid, Erin Miller, Kelly K. O'Brien, Kieran L. Quinn Background Given the chronic immune activation and inflammatory...
  4. SNT Gatchaman

    Preprint Large-scale brain network analysis reveals functional-structural dissynchrony in HIV-associated asymptomatic neurocognitive disorders, 2024, Zhou+

    Large-scale brain network analysis reveals functional-structural dissynchrony in HIV-associated asymptomatic neurocognitive disorders: Functional disturbances precede structural changes Zhongkai Zhou; Wenru Gong; Hong Hu; Fuchun Wang; Hui Li; Fan Xu; Hongjun Li; Wei Wang BACKGROUND In the era...
  5. cassava7

    Seventh patient ‘cured’ of HIV: why scientists are excited (Nature, 2024)

    A man in Germany is HIV-free after receiving stem cells that are not resistant to the virus. A 60-year-old man in Germany has become at least the seventh person with HIV to be announced free of the virus after receiving a stem-cell transplant1. But the man, who has been virus-free for close to...
  6. SNT Gatchaman

    Microfluidic Isolation of Neuronal-Enriched Extracellular Vesicles Shows Distinct and Common Neurological Proteins in LC, HIV & AD, 2024, Pulliam+

    Microfluidic Isolation of Neuronal-Enriched Extracellular Vesicles Shows Distinct and Common Neurological Proteins in Long COVID, HIV Infection and Alzheimer’s Disease Pulliam, Lynn; Sun, Bing; McCafferty, Erin; Soper, Steven A.; Witek, Malgorzata A.; Hu, Mengjia; Ford, Judith M.; Song, Sarah...
  7. SNT Gatchaman

    Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study, 2024, Yendewa et al.

    Associations between post-acute sequelae of SARS-CoV-2, COVID-19 vaccination and HIV infection: a United States cohort study Yendewa, George A.; Perez, Jaime Abraham; Patil, Nirav; McComsey, Grace A. People with HIV (PWH) are at higher risk of complications from acute COVID-19, but their risk...
  8. E

    Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study, 2023, McKAy et al

    Risk of Multiple Sclerosis in People Living with HIV: An International Cohort Study Abstract Objective There has been interest in a possible negative association between HIV and multiple sclerosis (MS). We aimed to compare the risk of MS in a cohort of individuals living with HIV to that in...
  9. SNT Gatchaman

    Impaired gut microbiota-mediated short-chain fatty acid production precedes morbidity and mortality in people with HIV, 2023, Sereti et al.

    Impaired gut microbiota-mediated short-chain fatty acid production precedes morbidity and mortality in people with HIV Irini Sereti; Myrthe L. Verburgh; Jacob Gifford; Alice Lo; Anders Boyd; Eveline Verheij; Aswin Verhoeven; Ferdinand W.N.M. Wit; Maarten F. Schim van der Loeff; Martin Giera...
  10. SNT Gatchaman

    In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation, 2023

    In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation Jensen et al Despite scientific evidence originating from two patients published to date that CCR5Δ32/Δ32 hematopoietic stem cell transplantation (HSCT) can...
  11. RedFox

    HIV vaccine succeeds in Phase 1 trial

    Vaccination induces HIV broadly neutralizing antibody precursors in humans https://www.science.org/doi/10.1126/science.add6502
  12. RedFox

    Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection

    Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection Open access: https://journals.lww.com/aidsonline/Fulltext/2022/10010/Postacute_sequelae_and_adaptive_immune_responses.1.aspx Abstract: Background: Limited data are available on the long-term...
  13. Mij

    Post-acute sequelae and adaptive immune responses in people living with HIV recovering from SARS-COV-2 infection, 2022, Peluso, Michael et al

    Abstract Background: Limited data are available on the long-term clinical and immunologic consequences of SARS-CoV-2 infection in people with HIV (PWH). Methods: We measured SARS-CoV-2-specific humoral and cellular responses in people with and without HIV recovering from COVID-19 (n = 39 and...
  14. Mij

    The Effects of Acute Aerobic Exercise on Blood Pressure, Arterial Function, and Heart Rate Variability in Men Living With HIV, 2021, Juliana P Barros

    Purpose: This study aims to investigate the effects of acute cycling on blood pressure (BP), arterial function, and heart rate variability (HRV) in men living with HIV (MLHIV) using combined antiretroviral therapy (cART). Methods: Twelve MLHIV (48.7 ± 9.2 years; 25.2 ± 2.8 kg m–2) and 13...
  15. D

    Lipophagy confers a key metabolic advantage that ensures protective CD8A T-cell responses against HIV-1, 2020, Loucif et al

    https://www.tandfonline.com/doi/full/10.1080/15548627.2021.1874134 The news article got me interested because of the reference to "restores mitochondiral energy metabolism" Scientists demonstrated that the strength of elite controllers comes from their energy metabolism within CD8 lymphocytes...
  16. J

    The ‘London Patient,’ Cured of H.I.V., Reveals His Identity

    https://www.nytimes.com/2020/03/09/health/hiv-aids-london-patient-castillejo.html?searchResultPosition=2 If there was a genotype that was resistant to MECFS, then perhaps we could undergo bone marrow transplants like this guy.
  17. Andy

    Trial By Error: New Biopsychosocial Study of Fatigue in HIV Patients

    http://www.virology.ws/2020/03/02/trial-by-error-new-biopsychosocial-study-of-fatigue-in-hiv-patients/
  18. Andy

    A Biopsychosocial Approach to HIV Fatigue: A Cross-Sectional and Prospective Analysis to Identify Key Modifiable Factors, 2020, Chalder et al

    Paywall, https://www.tandfonline.com/doi/full/10.1080/08964289.2020.1712582 Sci hub, https://sci-hub.tw/10.1080/08964289.2020.1712582
  19. J

    Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo (2020) Nixon et al

    https://www.nature.com/articles/s41586-020-1951-3 Only in mice and monkeys but quite interesting that they are flushing out a latent virus. And great if they can use it to eliminate HIV as well, of course.
  20. Patient4Life

    Scientists discover first new HIV strain in nearly two decades By Jen Christensen, CNN (Nov 7, 2019)

    Scientists discover first new HIV strain in nearly two decades By Jen Christensen, CNN (Nov 7, 2019)
Back
Top Bottom